Nicholas Hoffman & Company’s MiMedx Group MDXG Stock Holding History

Nicholas Hoffman & Company’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,305	Closed	-$62K	–	280
2021 Q4	$62K	Hold	10,305	–	–	﹤0.01%	269
2021 Q3	$62K	Hold	10,305	–	–	0.01%	263
2021 Q2	$129K	Buy	+10,305	New	+$112K	0.02%	263
2018 Q2	–	Sell	-159,385	Closed	-$1.11M	–	176
2018 Q1	$1.11M	Buy	159,385 +10,000	+7%	+$116K	0.43%	58
2017 Q4	$1.88M	Sell	149,385 -20,000	-12%	-$244K	0.74%	30
2017 Q3	$2.01M	Sell	169,385 -10,000	-6%	-$148K	0.85%	28
2017 Q2	$2.69M	Sell	179,385 -60,000	-25%	-$801K	1.22%	17
2017 Q1	$2.28M	Buy	239,385 +20,000	+9%	+$169K	1.07%	19
2016 Q4	$1.92M	Sell	219,385 -36,000	-14%	-$323K	0.97%	23
2016 Q3	$2.19M	Hold	255,385	–	–	1.2%	18
2016 Q2	$2.04M	Buy	+255,385	New	+$1.99M	1.18%	19

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BMO

Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return

Nicholas Hoffman & Company's MDXG Position: Q1 2022 in Review

Nicholas Hoffman & Company sold out of MiMedx Group (MDXG) in Q1 2022, closing a stake of 10,305 shares — an estimated $62K sold.

Nicholas Hoffman & Company first reported a position in MDXG in Q2 2016 and held it in 11 quarters. The position peaked at $2.69M in Q2 2017. 150 funds tracked by Wall St. Rank hold MDXG as of Q1 2022.

Nicholas Hoffman & Company reported no remaining MiMedx Group position as of Q1 2022 after selling out during the quarter.
Nicholas Hoffman & Company sold 10,305 MiMedx Group shares in Q1 2022, an estimated $62K.
Nicholas Hoffman & Company first reported a position in MiMedx Group in Q2 2016 and held it in 11 quarters.
Nicholas Hoffman & Company's MiMedx Group position peaked at $2.69M in Q2 2017.
150 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2022.

Based on Nicholas Hoffman & Company's 13F filing for Q1 2022, filed 10 May 2022.